Navigation Links
PATHFAST(R): Rapid Whole Blood Immunoassay Analyzer from Polymedco
Date:4/11/2008

CORTLANDT MANOR, N.Y., April 11 /PRNewswire/ -- Polymedco, Inc. is pleased to announce the introduction of the PATHFAST immunoassay analyzer. The PATHFAST rapid point of care system utilizes a chemiluminescent technology combined with a unique magtration separation method that allows this system to report highly accurate results that compare to large platform instruments. The PATHFAST system employs individual cartridge-based technology utilizing a whole blood sample.

The PATHFAST system can handle six samples in batch or random access mode and report these six results in 17 minutes. The PATHFAST analyzer and NTproBNP assay have recently been 510(k) cleared by the FDA. Polymedco has submitted another assay with the FDA and will file three more by the end of April. Polymedco expects to have seven assays cleared by the end of 2008. The initial menu will be related to cardiac proteins, fibrin degradation products, high sensitive c-reactive protein and beta human chorionic gonadotropin.

The PATHFAST system is a small, compact platform, which includes a computer, LCD touch screen and printer and measures W14.7" x D22.4" x H20.0". This self contained unit can easily fit on any laboratory bench. Its user friendly operation allows the technician to simply add blood to the cartridges, place them on the system and press the start button. The technician returns in 17 minutes to read the results. This sensitive technology will allow the laboratory to report NTproBNP results from 15-30,000 pg/mL.

Polymedco, Inc. is a leading manufacturing, marketing and sales company that specializes in bringing innovative equipment and diagnostic kits to the medical market.

For more information, please contact Polymedco at 800-431-2123 or 914-739-5400 or visit our website: http://www.polymedco.com


'/>"/>
SOURCE Polymedco, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related medicine news :

1. Sewer-gas-induced suspended animation is rapid and reversible
2. STMicroelectronics and Veredus Laboratories Launch Markets First Lab-on-Chip for Rapid Molecular Flu Detection at Point of Need
3. Cardiums InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems
4. Varian Announces Global Clinical Council to Develop RapidArc(TM) Cancer Treatments
5. HHS Deputy Secretary Recognizes Grand Rapids Leaders for Improving Quality and Value in Health Care
6. Harris Corporation Demonstrates Digital Signage(TM) Solutions for Dynamic, Rapid Communications within Healthcare Enterprises
7. Varian Medical Systems Announces Symposia on RapidArc Technology for Faster, More Precise Radiotherapy Treatments
8. Mybank Goes Live With Misys Equation to Support Rapid Growth and Meet Future Regulatory Requirements
9. Varian and BrainLAB Announce Rapid Uptake of Powerful and Versatile Radiosurgery Platform
10. Forsyth launches 1-of-a-kind core service to enable rapid identification of bacterial samples
11. Varian Medical Systems Receives FDA 510(k) Clearance for RapidArc(TM) Radiotherapy Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/9/2009).../PRNewswire-FirstCall/ - Hard to Treat Diseases (H...ntly completed a merger with Slavica Bio Chem (For... billion shares to pay for the Slavica merger and ...or Slavica is 300 million non-dilatable restricted...lved in Belgrade Serbia research. Key medical cons...
(Date:1/8/2009)...ire/ -- New York City Mayor Michael R. Bloomberg d..." and presented a proclamation to Ilchi Lee, presi...iation) and developer of Brain Education, a revolu...alth, well-being, and mental ability for all ages....ding the power of individuals to change themselves...
(Date:1/8/2009)...e/ -- A study released this week showing that a gr...ple chronic diseases shines a much-needed spotligh... to one that focuses on primary and secondary prev... leader in disease prevention. , , (Logo: h...9LOGO ) , , The study, conducted by Social &a...
(Date:1/8/2009)...enator Daschle at his confirmation hearing to be t... , , WASHINGTON, Jan. 8 /PRNewswire-USNewswire/...member Senator Tom Daschle, nominee for Department...duced by fellow BPC founder and friend Senator Bob...ng was convened by the Senate Health, Education, L...
Breaking Medicine News(10 mins):Health News:Hard To Treat Diseases (HTDS) Recapitalization 2Health News:NYC Mayor Michael R. Bloomberg Declares January 8th 'IBREA Brain Education Day' 2Health News:U.S. Preventive Medicine: Chronic Disease Study Demonstrates Need for Focus on Primary and Secondary Prevention 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 3Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 4
...gic reaction caused to many human beings. A new Ma...// allergic contact dermatitis. The exact definiti...ammation resulting in swollen, reddened and itchy ...rgen. The ten allergens identified by the mayo st...
...y foods seemed to score less in nutrition value be...nutrients, // like iron and protein. Sales of orga...four babies are growing up on daily helpings of th... appropriate labeling of baby food , came into for...
...a sudden emotional stress could weaken the heart. ...failure// in romance are said to be the triggering...archers at Johns Hopkins University found that sho...that mimic a serious heart attack causing severe h...
...nt officials that the much dreaded bird flu virus ... in UK//. The feral birds have the potential of po...urban areas, as they are susceptible to infection ...exact mechanism of how pigeons contract the infect...
Other Medicine News:
(Date:1/9/2009).../ -- ESBATech AG, a leading developer of antibody ...ion of the Phase I/IIa clinical development of its...arthritis (OA). This double-blind, randomized, pla...gned to investigate the safety, tolerability and e...ntra-articular administration to patients with sev...
(Date:1/8/2009)...wire-FirstCall/ -- , - ThromboGenics, Lead ...acular Adhesion in the US and Europe , Thro...logy company,focused on innovative treatments for...ces today that it has started the Phase III clinic...reatment of back of the eye disease, the,final st...
(Date:1/8/2009)...econd indication with clinical-stage, systemically...ONT, Calif., Jan. 8 Quark Pharmace...company discovering and developing novel RNA inter... that it has initiated patient dosing in its Phase...dministered siRNA drug candidate QPI-1002 (previou...
(Date:1/8/2009)...te Novel Gene Expression Biomarkers Involved in Wo...rm , , FREMONT, Calif., Jan. 8 /PRNewswire-Firs...Board: WGBS), a leading developer of state-of-the-...stem cell research systems, today announced the si...sity of Texas Southwestern Medical Center for the...
Breaking Medicine Technology:ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 2ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 3ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 4ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 2ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 3ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 4Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 2Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 3Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5Media Affects Public Perception of Infectious Diseases 28442 1Media Affects Public Perception of Infectious Diseases 28442 2Senator Obama Explains His Health Care Plan to SpineUniverse com 28439 1Senator Obama Explains His Health Care Plan to SpineUniverse com 28439 2Senator Obama Explains His Health Care Plan to SpineUniverse com 28439 3Natural Hormone Balance 3A Gaining Ground in the Fight Against Breast Cancer 28436 1Natural Hormone Balance 3A Gaining Ground in the Fight Against Breast Cancer 28436 2If metastasectomy should be performed before other treatments 28433 1If metastasectomy should be performed before other treatments 28433 2
...tive lens delivering magnification of 2.0x, 2.5x a...f use. Movement whilst maintaining focal clarity i...The ultra lightweight aluminum bar and individual ...he mounted loupes and optimal focal alignment, eli...
...tive lens delivering magnification of 2.0x, 2.5x a...f use. Movement whilst maintaining focal clarity i...The ultra lightweight aluminum bar and individual ...he mounted loupes and optimal focal alignment, eli...
Utilized for capsulotomies, nucleus dislocating, and other intraocular applications. Formed (bent) cystitomes are angled to conform to the convexity of the lens, providing easier access to the anteri
23 gauge thin wall irrigation. 25 gauge thin wall aspiration. Angled 30 degree shaft 8 mm from tip to bend. Irrigation tip set 0.5 mm behind aspiration tip. Dual hub construction. Polished finish. Ov
Medicine Products: